ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,960,930 | +94.0% | 956,556 | +119.7% | 0.06% | +56.1% |
| Q2 2023 | $13,382,044 | -27.8% | 435,330 | -15.4% | 0.04% | -46.1% |
| Q1 2023 | $18,544,965 | +63.4% | 514,709 | +79.2% | 0.08% | +68.9% |
| Q4 2022 | $11,352,871 | +206.9% | 287,269 | +212.1% | 0.04% | +136.8% |
| Q3 2022 | $3,699,000 | -50.4% | 92,055 | -48.1% | 0.02% | -53.7% |
| Q2 2022 | $7,451,000 | +5.9% | 177,240 | -1.9% | 0.04% | +36.7% |
| Q1 2022 | $7,038,000 | -52.1% | 180,653 | -51.0% | 0.03% | -23.1% |
| Q4 2021 | $14,706,000 | +72.0% | 369,028 | +56.0% | 0.04% | +56.0% |
| Q3 2021 | $8,550,000 | +18.4% | 236,593 | +34.3% | 0.02% | -7.4% |
| Q2 2021 | $7,220,000 | +1035.2% | 176,152 | +1108.0% | 0.03% | +575.0% |
| Q1 2021 | $636,000 | -40.1% | 14,582 | -31.2% | 0.00% | -50.0% |
| Q4 2020 | $1,061,000 | -89.1% | 21,193 | -89.4% | 0.01% | -94.9% |
| Q2 2020 | $9,710,000 | – | 200,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |